Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Rotavirus Vaccine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Rotavirus Vaccine worldwide and market share by regions, with company and product introduction, position in the Rotavirus Vaccine market
Market status and development trend of Rotavirus Vaccine by types and applications
Cost and profit status of Rotavirus Vaccine, and marketing status
Market growth drivers and challenges
The report segments the global Rotavirus Vaccine market as:
Global Rotavirus Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Rotavirus Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral
Others
Global Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinics
Public Services
Others
Global Rotavirus Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
Merck
GSK
Sanofi
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Rotavirus Vaccine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Rotavirus Vaccine worldwide and market share by regions, with company and product introduction, position in the Rotavirus Vaccine market
Market status and development trend of Rotavirus Vaccine by types and applications
Cost and profit status of Rotavirus Vaccine, and marketing status
Market growth drivers and challenges
The report segments the global Rotavirus Vaccine market as:
Global Rotavirus Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Rotavirus Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Oral
Others
Global Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinics
Public Services
Others
Global Rotavirus Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
Merck
GSK
Sanofi
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ROTAVIRUS VACCINE
1.1 Definition of Rotavirus Vaccine in This Report
1.2 Commercial Types of Rotavirus Vaccine
1.2.1 Oral
1.2.2 Others
1.3 Downstream Application of Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Clinics
1.3.3 Public Services
1.3.4 Others
1.4 Development History of Rotavirus Vaccine
1.5 Market Status and Trend of Rotavirus Vaccine 2013-2023
1.5.1 Global Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Rotavirus Vaccine 2013-2017
2.2 Sales Market of Rotavirus Vaccine by Regions
2.2.1 Sales Volume of Rotavirus Vaccine by Regions
2.2.2 Sales Value of Rotavirus Vaccine by Regions
2.3 Production Market of Rotavirus Vaccine by Regions
2.4 Global Market Forecast of Rotavirus Vaccine 2018-2023
2.4.1 Global Market Forecast of Rotavirus Vaccine 2018-2023
2.4.2 Market Forecast of Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Rotavirus Vaccine by Types
3.2 Sales Value of Rotavirus Vaccine by Types
3.3 Market Forecast of Rotavirus Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Rotavirus Vaccine by Downstream Industry
4.2 Global Market Forecast of Rotavirus Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Rotavirus Vaccine Market Status by Countries
5.1.1 North America Rotavirus Vaccine Sales by Countries (2013-2017)
5.1.2 North America Rotavirus Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Rotavirus Vaccine Market Status (2013-2017)
5.1.4 Canada Rotavirus Vaccine Market Status (2013-2017)
5.1.5 Mexico Rotavirus Vaccine Market Status (2013-2017)
5.2 North America Rotavirus Vaccine Market Status by Manufacturers
5.3 North America Rotavirus Vaccine Market Status by Type (2013-2017)
5.3.1 North America Rotavirus Vaccine Sales by Type (2013-2017)
5.3.2 North America Rotavirus Vaccine Revenue by Type (2013-2017)
5.4 North America Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Rotavirus Vaccine Market Status by Countries
6.1.1 Europe Rotavirus Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Rotavirus Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Rotavirus Vaccine Market Status (2013-2017)
6.1.4 UK Rotavirus Vaccine Market Status (2013-2017)
6.1.5 France Rotavirus Vaccine Market Status (2013-2017)
6.1.6 Italy Rotavirus Vaccine Market Status (2013-2017)
6.1.7 Russia Rotavirus Vaccine Market Status (2013-2017)
6.1.8 Spain Rotavirus Vaccine Market Status (2013-2017)
6.1.9 Benelux Rotavirus Vaccine Market Status (2013-2017)
6.2 Europe Rotavirus Vaccine Market Status by Manufacturers
6.3 Europe Rotavirus Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Rotavirus Vaccine Sales by Type (2013-2017)
6.3.2 Europe Rotavirus Vaccine Revenue by Type (2013-2017)
6.4 Europe Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Rotavirus Vaccine Market Status by Countries
7.1.1 Asia Pacific Rotavirus Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Rotavirus Vaccine Revenue by Countries (2013-2017)
7.1.3 China Rotavirus Vaccine Market Status (2013-2017)
7.1.4 Japan Rotavirus Vaccine Market Status (2013-2017)
7.1.5 India Rotavirus Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Rotavirus Vaccine Market Status (2013-2017)
7.1.7 Australia Rotavirus Vaccine Market Status (2013-2017)
7.2 Asia Pacific Rotavirus Vaccine Market Status by Manufacturers
7.3 Asia Pacific Rotavirus Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Rotavirus Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Rotavirus Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Rotavirus Vaccine Market Status by Countries
8.1.1 Latin America Rotavirus Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Rotavirus Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Rotavirus Vaccine Market Status (2013-2017)
8.1.4 Argentina Rotavirus Vaccine Market Status (2013-2017)
8.1.5 Colombia Rotavirus Vaccine Market Status (2013-2017)
8.2 Latin America Rotavirus Vaccine Market Status by Manufacturers
8.3 Latin America Rotavirus Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Rotavirus Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Rotavirus Vaccine Revenue by Type (2013-2017)
8.4 Latin America Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Rotavirus Vaccine Market Status by Countries
9.1.1 Middle East and Africa Rotavirus Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Rotavirus Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Rotavirus Vaccine Market Status (2013-2017)
9.1.4 Africa Rotavirus Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Rotavirus Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Rotavirus Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Rotavirus Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Rotavirus Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ROTAVIRUS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Rotavirus Vaccine by Major Manufacturers
11.2 Production Value of Rotavirus Vaccine by Major Manufacturers
11.3 Basic Information of Rotavirus Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Rotavirus Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Rotavirus Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Merck
12.1.1 Company profile
12.1.2 Representative Rotavirus Vaccine Product
12.1.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Rotavirus Vaccine Product
12.2.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.3 Sanofi
12.3.1 Company profile
12.3.2 Representative Rotavirus Vaccine Product
12.3.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ROTAVIRUS VACCINE
13.1 Industry Chain of Rotavirus Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ROTAVIRUS VACCINE
14.1 Cost Structure Analysis of Rotavirus Vaccine
14.2 Raw Materials Cost Analysis of Rotavirus Vaccine
14.3 Labor Cost Analysis of Rotavirus Vaccine
14.4 Manufacturing Expenses Analysis of Rotavirus Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Rotavirus Vaccine in This Report
1.2 Commercial Types of Rotavirus Vaccine
1.2.1 Oral
1.2.2 Others
1.3 Downstream Application of Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Clinics
1.3.3 Public Services
1.3.4 Others
1.4 Development History of Rotavirus Vaccine
1.5 Market Status and Trend of Rotavirus Vaccine 2013-2023
1.5.1 Global Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Rotavirus Vaccine 2013-2017
2.2 Sales Market of Rotavirus Vaccine by Regions
2.2.1 Sales Volume of Rotavirus Vaccine by Regions
2.2.2 Sales Value of Rotavirus Vaccine by Regions
2.3 Production Market of Rotavirus Vaccine by Regions
2.4 Global Market Forecast of Rotavirus Vaccine 2018-2023
2.4.1 Global Market Forecast of Rotavirus Vaccine 2018-2023
2.4.2 Market Forecast of Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Rotavirus Vaccine by Types
3.2 Sales Value of Rotavirus Vaccine by Types
3.3 Market Forecast of Rotavirus Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Rotavirus Vaccine by Downstream Industry
4.2 Global Market Forecast of Rotavirus Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Rotavirus Vaccine Market Status by Countries
5.1.1 North America Rotavirus Vaccine Sales by Countries (2013-2017)
5.1.2 North America Rotavirus Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Rotavirus Vaccine Market Status (2013-2017)
5.1.4 Canada Rotavirus Vaccine Market Status (2013-2017)
5.1.5 Mexico Rotavirus Vaccine Market Status (2013-2017)
5.2 North America Rotavirus Vaccine Market Status by Manufacturers
5.3 North America Rotavirus Vaccine Market Status by Type (2013-2017)
5.3.1 North America Rotavirus Vaccine Sales by Type (2013-2017)
5.3.2 North America Rotavirus Vaccine Revenue by Type (2013-2017)
5.4 North America Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Rotavirus Vaccine Market Status by Countries
6.1.1 Europe Rotavirus Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Rotavirus Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Rotavirus Vaccine Market Status (2013-2017)
6.1.4 UK Rotavirus Vaccine Market Status (2013-2017)
6.1.5 France Rotavirus Vaccine Market Status (2013-2017)
6.1.6 Italy Rotavirus Vaccine Market Status (2013-2017)
6.1.7 Russia Rotavirus Vaccine Market Status (2013-2017)
6.1.8 Spain Rotavirus Vaccine Market Status (2013-2017)
6.1.9 Benelux Rotavirus Vaccine Market Status (2013-2017)
6.2 Europe Rotavirus Vaccine Market Status by Manufacturers
6.3 Europe Rotavirus Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Rotavirus Vaccine Sales by Type (2013-2017)
6.3.2 Europe Rotavirus Vaccine Revenue by Type (2013-2017)
6.4 Europe Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Rotavirus Vaccine Market Status by Countries
7.1.1 Asia Pacific Rotavirus Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Rotavirus Vaccine Revenue by Countries (2013-2017)
7.1.3 China Rotavirus Vaccine Market Status (2013-2017)
7.1.4 Japan Rotavirus Vaccine Market Status (2013-2017)
7.1.5 India Rotavirus Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Rotavirus Vaccine Market Status (2013-2017)
7.1.7 Australia Rotavirus Vaccine Market Status (2013-2017)
7.2 Asia Pacific Rotavirus Vaccine Market Status by Manufacturers
7.3 Asia Pacific Rotavirus Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Rotavirus Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Rotavirus Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Rotavirus Vaccine Market Status by Countries
8.1.1 Latin America Rotavirus Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Rotavirus Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Rotavirus Vaccine Market Status (2013-2017)
8.1.4 Argentina Rotavirus Vaccine Market Status (2013-2017)
8.1.5 Colombia Rotavirus Vaccine Market Status (2013-2017)
8.2 Latin America Rotavirus Vaccine Market Status by Manufacturers
8.3 Latin America Rotavirus Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Rotavirus Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Rotavirus Vaccine Revenue by Type (2013-2017)
8.4 Latin America Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Rotavirus Vaccine Market Status by Countries
9.1.1 Middle East and Africa Rotavirus Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Rotavirus Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Rotavirus Vaccine Market Status (2013-2017)
9.1.4 Africa Rotavirus Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Rotavirus Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Rotavirus Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Rotavirus Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Rotavirus Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ROTAVIRUS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Rotavirus Vaccine by Major Manufacturers
11.2 Production Value of Rotavirus Vaccine by Major Manufacturers
11.3 Basic Information of Rotavirus Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Rotavirus Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Rotavirus Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Merck
12.1.1 Company profile
12.1.2 Representative Rotavirus Vaccine Product
12.1.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Rotavirus Vaccine Product
12.2.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.3 Sanofi
12.3.1 Company profile
12.3.2 Representative Rotavirus Vaccine Product
12.3.3 Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ROTAVIRUS VACCINE
13.1 Industry Chain of Rotavirus Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ROTAVIRUS VACCINE
14.1 Cost Structure Analysis of Rotavirus Vaccine
14.2 Raw Materials Cost Analysis of Rotavirus Vaccine
14.3 Labor Cost Analysis of Rotavirus Vaccine
14.4 Manufacturing Expenses Analysis of Rotavirus Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
